Oxbow Advisors LLC reduced its stake in shares of Vanguard Russell 1000 (NASDAQ:VONE – Free Report) by 4.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,420 shares of the company’s stock after selling 65 shares during the quarter. Oxbow Advisors LLC’s holdings in Vanguard Russell 1000 were worth $379,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also modified their holdings of the company. Synergy Asset Management LLC bought a new stake in shares of Vanguard Russell 1000 during the fourth quarter valued at about $47,000. Venturi Wealth Management LLC bought a new stake in shares of Vanguard Russell 1000 during the third quarter valued at about $50,000. MCF Advisors LLC bought a new stake in shares of Vanguard Russell 1000 during the fourth quarter valued at about $64,000. Human Investing LLC bought a new stake in shares of Vanguard Russell 1000 during the fourth quarter valued at about $81,000. Finally, Avior Wealth Management LLC bought a new stake in shares of Vanguard Russell 1000 during the third quarter valued at about $91,000.
Vanguard Russell 1000 Stock Down 1.8 %
NASDAQ:VONE opened at $272.95 on Friday. The business’s 50-day moving average price is $272.71 and its 200 day moving average price is $265.17. The firm has a market cap of $5.52 billion, a P/E ratio of 24.78 and a beta of 1.02. Vanguard Russell 1000 has a 52-week low of $224.66 and a 52-week high of $279.48.
Vanguard Russell 1000 Dividend Announcement
Vanguard Russell 1000 Company Profile
The Vanguard Russell 1000 ETF (VONE) is an exchange-traded fund that is based on the Russell 1000 index, a market-cap-weighted index of the 1000 largest US companies. VONE was launched on Sep 20, 2010 and is managed by Vanguard.
Further Reading
- Five stocks we like better than Vanguard Russell 1000
- Market Cap Calculator: How to Calculate Market Cap
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Top Biotech Stocks: Exploring Innovation Opportunities
- DuPont’s Electronics Spinoff: The Start of Something Big
- Stock Market Upgrades: What Are They?
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Want to see what other hedge funds are holding VONE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vanguard Russell 1000 (NASDAQ:VONE – Free Report).
Receive News & Ratings for Vanguard Russell 1000 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vanguard Russell 1000 and related companies with MarketBeat.com's FREE daily email newsletter.